Carlos Thadeu Schmidt Cerski

4PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNeonatologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 04, 2025
Potential Beneficial Effect of Rifaximin in the Prevention of Hepatocellular Carcinoma through the Modulation of the Microbiota in an Experimental Model of Non-alcoholic Fatty Liver Disease.

Jéssica Tonin Ferrari, Gabriel Tayguara Silveira Guerreiro, Larisse Longo

|Dec 21, 2023
Clinical outcomes and prognostic factors of head and neck squamous cell carcinoma: a ten-year follow-up study.

Kelly Bienk Dias, Laura Campos Hildebrand, Ana Luísa Homem de Carvalho

|Oct 27, 2022
Protocols of Investigation of Neonatal Cholestasis-A Critical Appraisal.

Patricia Quelhas, Joana Jacinto, Carlos Cerski

|Apr 16, 2022
Nuclear morphometry and chromatin texture changes in hepatocellular carcinoma samples may predict outcomes of liver transplanted patients.

Jordan Boeira Dos Santos, Rodrigo Tzovenos Starosta, Emily Ferreira Salles Pilar

Pageof 1